Cargando…

Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors

Detalles Bibliográficos
Autor principal: Tabrizchi, Reza
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993996/
https://www.ncbi.nlm.nih.gov/pubmed/17319452
_version_ 1782135464465006592
author Tabrizchi, Reza
author_facet Tabrizchi, Reza
author_sort Tabrizchi, Reza
collection PubMed
description
format Text
id pubmed-1993996
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-19939962008-03-06 Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors Tabrizchi, Reza Vasc Health Risk Manag Editorial Foreword Dove Medical Press 2006-06 2006-06 /pmc/articles/PMC1993996/ /pubmed/17319452 Text en © 2006 Dove Medical Press Limited. All rights reserved
spellingShingle Editorial Foreword
Tabrizchi, Reza
Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title_full Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title_fullStr Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title_full_unstemmed Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title_short Risk of Cardiovascular Events and Cyclooxygenase-2 Inhibitors
title_sort risk of cardiovascular events and cyclooxygenase-2 inhibitors
topic Editorial Foreword
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1993996/
https://www.ncbi.nlm.nih.gov/pubmed/17319452
work_keys_str_mv AT tabrizchireza riskofcardiovasculareventsandcyclooxygenase2inhibitors